Skip to main content
. 2019 Aug 14;10:869. doi: 10.3389/fneur.2019.00869

Figure 4.

Figure 4

Example of ultra-low dose 18F-florbetaben PET/MRI. Example of a positive 18F-florbetaben PET/MRI study acquired at 0.24 mCi, ~3% of a standard dose. Similar image quality is present in the 100% dose image and the synthetized image, which was created using a deep neural network along with MRI information such as T1, T2, and T2-FLAIR. As Alzheimer Disease studies are moving toward cognitively normal and younger patients, reducing dose would be helpful. Furthermore, tracer costs could be reduced if doses can be shared.